Pfizer Inc.
PFE
Peringkat dalam Saham
#121
Pfizer Inc. is a global biopharmaceutical leader engaged in the research,... Pfizer Inc. is a global biopharmaceutical leader engaged in the research, development, production, marketing, and distribution of a wide array of medicinal and vaccine products worldwide. Its comprehensive portfolio addresses diverse therapeutic areas, including cardiovascular health and women's health, featuring key brands such as the Premarin family and Eliquis. The company also offers advanced biologics, small molecule drugs, immunotherapies, and biosimilars for various conditions, exemplified by Ibrance, Xtandi, and Retacrit. Furthermore, Pfizer provides sterile injectables, anti-infective agents, and a significant oral treatment for COVID-19, including Paxlovid. A substantial portion of its offerings comprises vaccines for infectious diseases such as pneumococcal and meningococcal disease, tick-borne encephalitis, and COVID-19, with notable products like Comirnaty and the Prevnar family. The firm also develops biosimilars for chronic autoimmune and inflammatory disorders, including Inflectra and Xeljanz, alongside specialized therapies for rare conditions like amyloidosis, hemophilia, and endocrine disorders, under brands such as Vyndaqel and BeneFIX. Beyond its proprietary products, Pfizer operates a contract manufacturing division. Its extensive customer base includes wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual medical practices, and public health organizations. The company actively fosters strategic collaborations with numerous partners, such as Bristol-Myers Squibb Company, BioNTech SE, and Merck KGaA. Established in 1849, Pfizer Inc. is headquartered in New York, New York.
Harga Saham
$29.55
Terakhir disinkronkan: 2026-10-16
Kapitalisasi Pasar
$168.40B
Perubahan (1 hari)
0.37%
Perubahan (1 tahun)
20.54%
Negara
US
Perdagangan Pfizer Inc. (PFE)
Kategori
Healthcare
Margin Operasi untuk Pfizer Inc. (PFE)
Margin Operasi per October 2026 TTM: 25.08%
Menurut laporan keuangan dan harga saham terbaru dari Pfizer Inc., margin operasi saat ini (TTM) adalah 25.08%. Pada akhir 2024, margin operasi perusahaan adalah 25.91%.
Riwayat margin operasi untuk Pfizer Inc. dari 2000 hingga 2026
Margin Operasi pada akhir setiap tahun
| Tahun | Margin Operasi | Mengubah |
|---|---|---|
| 2026 (TTM) | 25.08% | 1.66% |
| 2025 | 24.67% | -4.79% |
| 2024 | 25.91% | 191.45% |
| 2023 | 8.89% | -76.25% |
| 2022 | 37.43% | 46.33% |
| 2021 | 25.58% | 17.29% |
| 2020 | 21.81% | 19.57% |
| 2019 | 18.24% | -36.00% |
| 2018 | 28.50% | 4.05% |
| 2017 | 27.39% | 1.37% |
| 2016 | 27.02% | -0.73% |
| 2015 | 27.22% | -3.75% |
| 2014 | 28.28% | -13.62% |
| 2013 | 32.74% | -0.79% |
| 2012 | 33.00% | 9.56% |
| 2011 | 30.12% | 13.92% |
| 2010 | 26.44% | -17.40% |
| 2009 | 32.01% | -7.00% |
| 2008 | 34.42% | 19.72% |
| 2007 | 28.75% | -7.85% |
| 2006 | 31.20% | 1.79% |
| 2005 | 30.65% | -5.81% |
| 2004 | 32.54% | 36.15% |
| 2003 | 23.90% | -36.99% |
| 2002 | 37.93% | 11.49% |
| 2001 | 34.02% | 16.03% |
| 2000 | 29.32% | 0.00% |
Margin Operasi untuk perusahaan sejenis atau pesaing
| Perusahaan | Margin Operasi | Perbedaan Margin Operasi | Negara |
|---|---|---|---|
| 49.72% | -98.02% |
US
|
|
| 25.70% | -98.98% |
US
|
|
| 29.32% | -98.83% |
US
|
|
| 26.59% | -98.94% |
CH
|
|
| 16.65% | -99.34% |
US
|
Apa itu Margin Operasi perusahaan?
Margin Operasi adalah indikator utama untuk menilai profitabilitas suatu perusahaan. Margin Operasi yang lebih tinggi umumnya lebih baik karena menunjukkan bahwa perusahaan mampu menjual produk atau layanan mereka dengan harga yang jauh lebih tinggi daripada biaya produksinya. Margin Operasi dihitung dengan membagi laba perusahaan dengan pendapatannya.